Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 1 50-1, 2004, Pages

  Thupari, Jagan N ^a   Kim, Eun Kyoung ^a   Moran, Timothy H ^a   Ronnett, Gabriele V ^a   Kuhajda, Francis P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carnitine palmitoyltransferase I; Fatty acid synthase; Neuropeptide Y

Indexed keywords

AMPHETAMINE; C 75; CARNITINE PALMITOYLTRANSFERASE; COCAINE; ENZYME INHIBITOR; FATTY ACID SYNTHASE; NEUROPEPTIDE; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; DIET; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FATTY LIVER; FOOD INTAKE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION;

4-BUTYROLACTONE; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; CHRONIC DISEASE; DIET; EATING; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FATTY LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; OXIDATION-REDUCTION; TREATMENT OUTCOME;

EID: 3042781707     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00261.2003     Document Type: Article

References (25)

1. Bergen HT, Mizuno T, Taylor J, and Mobbs CV. Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus. Brain Res 851: 198-203, 1999.
2. Carr TP, Andersen CJ, and Rudel LL. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26: 39-42, 1993.
3. Chen Y, Duhl DM, and Barsh GS. Opposite orientations of an inverted duplication and allelic variation at the mouse agouti locus. Genetics 144: 265-277, 1996.
4. Douglass J, McKinzie AA, and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15: 2471-2481, 1995.
5. Folch J, Lees M, and Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
6. Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, and Ronnett GV. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am J Physiol Endocrinol Metab 283: E867-E879, 2002.
7. Kuhajda FP, Pizer EP, Li JL, Mani NS, Frehywot GL, and Townsend CA. Synthesis and anti-tumor activity of a novel inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97: 3450-3454, 2000.
8. Kumar MV, Shimokawa T, Nagy TR, and Lane MD. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc Natl Acad Sci USA 99: 1921-1925, 2002.
9. Levin BE and Dunn-Meynell AA. Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 279: R2222-R2228, 2000.
10. Lieberman LS. Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes. Annu Rev Nutr 23: 345-377, 2003.
11. Loftus T, Jaworsky D, Frehywot G, Townsend C, Ronnett G, Lane M, and Kuhajda F. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288: 2379-2381, 2000.
12. McGarry JD and Brown NF. The mitochondrial carnitine palmitoyl- transferase system from concept to molecular analysis. Eur J Biochem 244: 1-14, 1997.
13. Minth CD, Bloom SR, Polak JM, and Dixon JE. Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 81: 4577-4581, 1984.
14. Mobbs CV and Makimura H. Block the FAS, lose the fat. Nat Med 8: 335-336, 2002.
15. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, and Marks JS. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289: 76-79, 2003.
16. Mystkowski P, Shankland E, Schreyer SA, LeBoeuf RC, Schwartz RS, Cummings DE, Kushmerick M, and Schwartz M. Validation of whole-body magnetic resonance spectroscopy as a tool to assess murine body composition. Int J Obes Relat Metab Disord 24: 719-724, 2000.
17. Neuschwander-Tetri BA and Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 27: 1202-1219, 2003.
18. Rohner-Jeanrenaud F, Craft LS, Bridwell J, Suter Tm Tinsley FC, Smiley DL, Burkhart DR, Statnick MA, Heiman ML, Ravussin E, and Caro JF. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostatis in lean and high-fat-fed obese rats. Int J Obes Relat Metab Disord 26: 143-149, 2002.
19. Shimokawa T, Kumar MV, and Lane MD. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic peptides. Proc Natl Acad Sci USA 99: 66-71, 2002.
20. Takahashi KA, Smart JL, Liu H, and Cone RD. The anorexigenic fatty acid synthase inhibitor, c75, is a nonspecific neuronal activator. Endocrinology 145: 184-193, 2004.
21. Thupari JN, Landree LE, Ronnett GV, and Kuhajda FP. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci USA 99: 9498-9502, 2002.
22. Uhler M and Herbert E. Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 258: 257-261, 1983.
23. Wakil S. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28: 4523-4530, 1989.
24. Wang H, Storlien LH, and Huang X. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 282: E1352-E1359, 2002.
25. Ziotopoulou M, Mantzoros CS, Hileman SM, and Flier JS. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279: E838-E845, 2000.